The U.S. National Institutes of Health (NIH) – the primary federal agency for biomedical research – slashed nearly 800 projects and vowed to wipe out billions of dollars from biomedical research ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

Discover six hemophilia companies developing new treatments for the genetic bleeding disorder, from gene therapies to RNAi ...

The antibody discovery landscape is at a turning point. As the demand for more effective and targeted therapeutics grows to tackle challenging targets, traditional methods—focused on binding rather ...